FDA warning letter
Issue date
6 Mar 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
19 Mar 2019
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Jubilant Generics
Manufacturer
Warning letter
Headquarters
IndiaSites
India